Emerging Anti-cancer Compounds and Immunomodulators for Pancreatic Cancer Treatment
- Stephen Safe
- Jennifer M. Bailey-Lundberg
- Kathleen E. DelGiorno
Paperback & Hardcover deals ―
Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks Wagon₹1,911Book ChorGOCrosswordGODC BooksGOe-book & Audiobook deals ―
Amazon India GOGoogle Play Books GOAudible GO* Price may vary from time to time.
* GO = We're not able to fetch the price (please check manually visiting the website).
Know about the book -
Emerging Anti-cancer Compounds and Immunomodulators for Pancreatic Cancer Treatment is written by Stephen Safe and published by Frontiers Media SA. It's available with International Standard Book Number or ISBN identification 2832548482 (ISBN 10) and 9782832548486 (ISBN 13).
Pancreatic cancer is a highly lethal gastrointestinal disease that is becoming one of the leading causes of cancer mortality worldwide. Despite advances in surgery, radiation therapy, immuno-oncology, and therapeutics, the 5-year survival rate for pancreatic cancer patients remains around 12%. The poor prognosis is mainly due to late diagnosis, as pancreatic cancer patients commonly don’t exhibit symptoms until an advanced stage that is beyond surgical resection. Currently, the main treatments for patients with advanced pancreatic cancer are chemotherapy, radiotherapy, and most recent clinical trials incorporate immunotherapy.
